Fractyl Health, Inc. SEC filings GUTS

Fractyl Health, Inc. has 227 filings in SEC EDGAR's recent list, going back to Mar 21, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.

Fractyl Health, Inc. SEC filings
Form Description Filed Period
8-K Current report
Exit or restructuring costs, Officer or director change, Other events
Oct 22, 2026 Oct 21, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 16, 2026 Oct 16, 2026
SCHEDULE 13G Ownership over 5% (passive) Oct 13, 2026 —
8-K Current report
Bylaw or fiscal year change
Oct 1, 2026 Sep 30, 2026
8-K Current report
Shareholder vote results
Sep 24, 2026 Sep 24, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
8-K Current report
Listing notice
Sep 11, 2026 Sep 10, 2026
DEF 14A Proxy statement Aug 24, 2026 Aug 24, 2026
PRE 14A Preliminary proxy statement Aug 14, 2026 Sep 24, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
8-K Current report
Regulation FD disclosure, Other events
Jul 15, 2026 Jul 15, 2026
4 Insider transaction Jun 15, 2026 Jun 12, 2026
8-K Current report
Shareholder vote results
Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 11, 2026 Jun 10, 2026
4 Insider transaction Jun 9, 2026 Jun 8, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 4, 2026 Jun 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 12, 2026 May 12, 2026
8-K Current report
Regulation FD disclosure
May 11, 2026 May 11, 2026
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Apr 23, 2026
10-K Annual report Mar 24, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 24, 2026 Mar 24, 2026
8-K Current report
Listing notice
Mar 17, 2026 Mar 13, 2026
8-K Current report
Regulation FD disclosure
Feb 26, 2026 Feb 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 4, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jan 29, 2026 Jan 29, 2026
4 Insider transaction Jan 14, 2026 Jan 12, 2026
3 Initial insider ownership Jan 14, 2026 Jan 12, 2026
S-8 Employee stock plan registration Jan 13, 2026 —
8-K Current report
Officer or director change, Regulation FD disclosure
Jan 6, 2026 Dec 30, 2025
8-K Current report
Results of operations, Other events
Jan 5, 2026 Jan 5, 2026
4 Insider transaction Dec 17, 2025 Dec 15, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 16, 2025 Dec 15, 2025
4 Insider transaction Dec 8, 2025 Dec 4, 2025
8-K Current report
Regulation FD disclosure, Other events
Dec 2, 2025 Dec 2, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 14, 2025 —
8-K Current report
Shareholder vote results
Oct 3, 2025 Oct 3, 2025
424B5 Prospectus supplement Sep 26, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Sep 26, 2025 Sep 26, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 26, 2025 Sep 26, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
3 Initial insider ownership Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
3 Initial insider ownership Sep 4, 2025 Sep 2, 2025
8-K Current report
Officer or director change
Sep 3, 2025 Aug 29, 2025
DEF 14A Proxy statement Aug 25, 2025 Oct 3, 2025
PRE 14A Preliminary proxy statement Aug 15, 2025 Oct 3, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 12, 2025 Aug 12, 2025
8-K Current report
Material agreement
Aug 7, 2025 Aug 6, 2025
424B5 Prospectus supplement Aug 7, 2025 —
424B5 Prospectus supplement Aug 5, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 23, 2025 Jun 23, 2025
8-K Current report
Regulation FD disclosure, Other events
Jun 18, 2025 Jun 18, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
8-K Current report
Shareholder vote results
Jun 12, 2025 Jun 11, 2025
8-K Current report
Regulation FD disclosure
May 19, 2025 May 19, 2025
8-K Current report
Regulation FD disclosure
May 19, 2025 May 17, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
10-Q Quarterly report May 13, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Apr 1, 2025 Apr 1, 2025
EFFECT Filing Mar 18, 2025 —
4/A Filing Mar 18, 2025 Mar 13, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
CORRESP Letter to the SEC Mar 13, 2025 —
S-3/A Filing Mar 13, 2025 —
8-K Current report
Other events
Mar 13, 2025 Mar 13, 2025
UPLOAD Letter from the SEC Mar 11, 2025 —
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
4 Insider transaction Mar 3, 2025 Feb 27, 2025
S-3 Shelf registration Mar 3, 2025 —
8-K Current report
Results of operations
Mar 3, 2025 Mar 3, 2025
10-K Annual report Mar 3, 2025 Dec 31, 2024
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 4, 2025 —
4 Insider transaction Feb 3, 2025 Jan 30, 2025
4 Insider transaction Feb 3, 2025 Jan 30, 2025
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Jan 31, 2025 Jan 31, 2025
144 Notice of proposed sale Jan 30, 2025 —
144 Notice of proposed sale Jan 30, 2025 —
8-K Current report
Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 13, 2024 Nov 10, 2024
4 Insider transaction Nov 13, 2024 Nov 10, 2024
SC 13G Ownership over 5% (passive) Nov 13, 2024 —
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
4 Insider transaction Sep 13, 2024 Sep 12, 2024
144 Notice of proposed sale Sep 12, 2024 —
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Regulation FD disclosure
Jul 30, 2024 Jul 30, 2024
8-K Current report
Regulation FD disclosure
Jun 24, 2024 Jun 24, 2024
3/A Form 3/a submission May 14, 2024 Feb 1, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
4 Insider transaction Apr 2, 2024 Apr 1, 2024
3 Initial insider ownership Apr 2, 2024 Apr 1, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
8-K Current report
Regulation FD disclosure
Apr 1, 2024 Apr 1, 2024
SC 13G Ownership over 5% (passive) Feb 16, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 8, 2024 Feb 6, 2024
4 Insider transaction Feb 6, 2024 Feb 6, 2024
S-8 Employee stock plan registration Feb 6, 2024 —
8-K Current report
Bylaw or fiscal year change, Other events
Feb 6, 2024 Feb 6, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
4 Insider transaction Feb 5, 2024 Feb 1, 2024
424B4 Prospectus Feb 2, 2024 —
SEC STAFF LETTER Filing Feb 1, 2024 —
EFFECT Filing Feb 1, 2024 —
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
3 Initial insider ownership Feb 1, 2024 Feb 1, 2024
CERT Filing Feb 1, 2024 —
CORRESP Letter to the SEC Jan 30, 2024 —
CORRESP Letter to the SEC Jan 30, 2024 —
8-A12B Filing Jan 29, 2024 —
CORRESP Letter to the SEC Jan 29, 2024 —
S-1/A Amended registration statement Jan 29, 2024 —
UPLOAD Letter from the SEC Dec 20, 2023 —
SEC STAFF LETTER Filing Dec 19, 2023 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
GUTS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Burlington, MA
SEC filer status
, Emerging growth company
SEC CIK
1572616
Former names
Fractyl Laboratories Inc. (until Mar 19, 2020)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.